Cellectar Biosciences Inc (CLRB.OQ)
CLRB.OQ on NASDAQ Stock Exchange Capital Market
1.99USD
17 Jan 2019
1.99USD
17 Jan 2019
Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$1.99
$1.99
Open
$1.96
$1.96
Day's High
$2.06
$2.06
Day's Low
$1.94
$1.94
Volume
16,095
16,095
Avg. Vol
33,397
33,397
52-wk High
$13.90
$13.90
52-wk Low
$1.22
$1.22
About
Cellectar Biosciences, Inc., formerly Novelos Therapeutics, Inc., is a clinical stage biopharmaceutical company. The Company is engaged in developing phospholipid ether-drug conjugates (PDCs) for the treatment and diagnostic imaging of cancer. Its research and development program is based on its PDC cancer targeting delivery... (more)
Overall
| Beta: | 1.02 |
| Market Cap(Mil.): | $23.88 |
| Shares Outstanding(Mil.): | 13.92 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CLRB.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 30.48 | 33.71 |
| EPS (TTM): | -1.24 | -- | -- |
| ROI: | -103.68 | 14.98 | 14.48 |
| ROE: | -105.20 | 16.31 | 15.99 |
Estimates